Frontlight ResearchEarly access
CompletedNo phase
Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms
Key facts
- Who runs it
- Methodist Health System
- Where
- Dallas, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 208 people enrolled
- Started
- 17 Jan 2023
- Ended
- 18 Jul 2025
- Type of study
- Observational
- Record updated
- 11 June 2026
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Age 18 years or older Diagnosed with cerebral aneurysms (i.e. ICD-10 i67.1) Pre-intervention treatment with clopidogrel
Who cannot take part
- Does not meet inclusion criteria specified in 3.1
Where in United States
- Methodist Dallas Medical CenterDallas, United States
About the trial
What the trial wants to find out
This registry study will investigate the incidence of and outcomes associated with clopidogrel hyper-responsive patients treated at Methodist Dallas Medical Center, beginning in January 2018, who suffered cerebral aneurysms.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 11 June 2026